Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 5
2009 3
2010 1
2011 2
2012 2
2013 5
2014 2
2015 6
2016 8
2017 8
2018 8
2019 6
2020 5
2021 17
2022 14
2023 13
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab-Associated Hypopituitarism.
Ogbue O, Garisa M, Furqan M, Alqaisi S, Patel R. Ogbue O, et al. Among authors: furqan m. Am J Ther. 2023 Nov-Dec 01;30(6):e583-e586. doi: 10.1097/MJT.0000000000001529. Epub 2022 Jun 15. Am J Ther. 2023. PMID: 37921684 No abstract available.
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.
Pant S, Wainberg ZA, Weekes CD, Furqan M, Kasi PM, Devoe CE, Leal AD, Chung V, Basturk O, VanWyk H, Tavares AM, Seenappa LM, Perry JR, Kheoh T, McNeil LK, Welkowsky E, DeMuth PC, Haqq CM, O'Reilly EM. Pant S, et al. Among authors: furqan m. Nat Med. 2024 Feb;30(2):531-542. doi: 10.1038/s41591-023-02760-3. Epub 2024 Jan 9. Nat Med. 2024. PMID: 38195752 Free PMC article. Clinical Trial.
Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages.
Mandula JK, Sierra-Mondragon RA, Jimenez RV, Chang D, Mohamed E, Chang S, Vazquez-Martinez JA, Cao Y, Anadon CM, Lee SB, Das S, Rocha-Munguba L, Pham VM, Li R, Tarhini AA, Furqan M, Dalton W, Churchman M, Moran-Segura CM, Nguyen J, Perez B, Kojetin DJ, Obermayer A, Yu X, Chen A, Shaw TI, Conejo-Garcia JR, Rodriguez PC. Mandula JK, et al. Among authors: furqan m. Immunity. 2024 May 14;57(5):1124-1140.e9. doi: 10.1016/j.immuni.2024.03.020. Epub 2024 Apr 17. Immunity. 2024. PMID: 38636522
Pericardial Involvement in Sarcoidosis.
Mahalwar G, Kumar A, Agrawal A, Bhat A, Furqan M, Yesilyaprak A, Verma BR, Chan N, Schleicher M, Neto MLR, Xu B, Jellis CL, Klein AL. Mahalwar G, et al. Among authors: furqan m. Am J Cardiol. 2022 May 1;170:100-104. doi: 10.1016/j.amjcard.2022.01.025. Epub 2022 Feb 25. Am J Cardiol. 2022. PMID: 35227500 Review.
COVID-19 Vaccine-Related Myocardial and Pericardial Inflammation.
Furqan M, Chawla S, Majid M, Mazumdar S, Mahalwar G, Harmon E, Klein A. Furqan M, et al. Curr Cardiol Rep. 2022 Dec;24(12):2031-2041. doi: 10.1007/s11886-022-01801-6. Epub 2022 Nov 28. Curr Cardiol Rep. 2022. PMID: 36441403 Free PMC article. Review.
Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy.
Zaher A, Stephens LM, Miller AM, Hartwig SM, Stolwijk JM, Petronek MS, Zacharias ZR, Wadas TJ, Monga V, Cullen JJ, Furqan M, Houtman JCD, Varga SM, Spitz DR, Allen BG. Zaher A, et al. Among authors: furqan m. Front Immunol. 2022 Aug 22;13:989000. doi: 10.3389/fimmu.2022.989000. eCollection 2022. Front Immunol. 2022. PMID: 36072595 Free PMC article. Review.
Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer.
Qiu B, Cai K, Chen C, Chen J, Chen KN, Chen QX, Cheng C, Dai TY, Fan J, Fan Z, Hu J, Hu WD, Huang YC, Jiang GN, Jiang J, Jiang T, Jiao WJ, Li HC, Li Q, Liao YD, Liu HX, Liu JF, Liu L, Liu Y, Long H, Luo QQ, Ma HT, Mao NQ, Pan XJ, Tan F, Tan LJ, Tian H, Wang D, Wang WX, Wei L, Wu N, Wu QC, Xiang J, Xu SD, Yang L, Zhang H, Zhang L, Zhang P, Zhang Y, Zhang Z, Zhu K, Zhu Y, Um SW, Oh IJ, Tomita Y, Watanabe S, Nakada T, Seki N, Hida T, Sasada S, Uchino J, Sugimura H, Dermime S, Cappuzzo F, Rizzo S, Cho WC, Crucitti P, Longo F, Lee KY, De Ruysscher D, Vanneste BGL, Furqan M, Sieren JC, Yendamuri S, Merrell KW, Molina JR, Metro G, Califano R, Bongiolatti S, Provencio M, Hofman P, Gao S, He J. Qiu B, et al. Among authors: furqan m. Transl Lung Cancer Res. 2021 Sep;10(9):3713-3736. doi: 10.21037/tlcr-21-634. Transl Lung Cancer Res. 2021. PMID: 34733623 Free PMC article. Review. No abstract available.
Novel agents for advanced pancreatic cancer.
Akinleye A, Iragavarapu C, Furqan M, Cang S, Liu D. Akinleye A, et al. Among authors: furqan m. Oncotarget. 2015 Nov 24;6(37):39521-37. doi: 10.18632/oncotarget.3999. Oncotarget. 2015. PMID: 26369833 Free PMC article. Review.
Pericardial Diseases in COVID19: a Contemporary Review.
Furqan MM, Verma BR, Cremer PC, Imazio M, Klein AL. Furqan MM, et al. Curr Cardiol Rep. 2021 Jun 3;23(7):90. doi: 10.1007/s11886-021-01519-x. Curr Cardiol Rep. 2021. PMID: 34081219 Free PMC article. Review.
115 results